706
Views
46
CrossRef citations to date
0
Altmetric
Articles

CD38 as a prognostic marker in CLL

Pages 39-46 | Published online: 04 Sep 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Pauline Y. Huang, O. Giles Best, Larissa Belov, Stephen P. Mulligan & Richard I. Christopherson. (2012) Surface profiles for subclassification of chronic lymphocytic leukemia. Leukemia & Lymphoma 53:6, pages 1046-1056.
Read now

Articles from other publishers (45)

Smyth Elizabeth, Kelly Aidan, O' Brien David, Waldron Deirdre, Brophy Sarah, Atkinson Emer, Perera Kanthi, Gerard M. Crotty, Walsh Aileen, Connolly Michelle, Clifford Ruth, O'Leary Hilary, Khan Ashique, Christopher L. Bacon, Smyth Emily, Anthony M. McElligott, Quinn Fiona, Vandenberghe Elisabeth & Waldron Carmel. (2022) Low CD49d expression in newly diagnosed chronic lymphocytic leukaemia may be associated with high‐risk features and reduced treatment‐free‐intervals. European Journal of Haematology 109:5, pages 441-446.
Crossref
Mohamed A. Kharfan-Dabaja, Farah Yassine, Martha E. Gadd & Hong Qin. (2022) Driving Out Chronic Lymphocytic Leukemia With CAR T Cells. Transplantation and Cellular Therapy 28:1, pages 5-17.
Crossref
Mili Jain, Anushree Rai, Rashmi Kushwaha, Geeta Yadav, Sanjay Mishra, Shailendra Prasad Verma, Uma Shankar Singh, Anil Kumar Tripathi & Ashutosh Kumar. (2021) A Cross Sectional Study on T Cells and Subsets in Chronic Lymphocytic Leukemia and their Association with Clinical Phenotype. Indian Journal of Hematology and Blood Transfusion 37:4, pages 563-568.
Crossref
Zhuang Ding, Yijia He, Yong Fu, Nisha Zhu, Mengxiang Zhao, Yuxian Song, Xiaofeng Huang, Sheng Chen, Yan Yang, Caihong Zhang, Qingang Hu, Yanhong Ni & Liang Ding. (2021) CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint. Frontiers in Oncology 11.
Crossref
Stefania Angelicola, Francesca Ruzzi, Lorena Landuzzi, Laura Scalambra, Francesco Gelsomino, Andrea Ardizzoni, Patrizia Nanni, Pier-Luigi Lollini & Arianna Palladini. (2021) IFN-γ and CD38 in Hyperprogressive Cancer Development. Cancers 13:2, pages 309.
Crossref
Jessica M. Konen, Jared J. Fradette & Don L. Gibbons. (2019) The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors. Cells 9:1, pages 52.
Crossref
Tina Vosoughi, Marziye Bagheri, Mehran Hosseinzadeh, Ali Ehsanpour, Nader Davari & Najmaldin Saki. (2019) CD markers variations in chronic lymphocytic leukemia: New insights into prognosis. Journal of Cellular Physiology 234:11, pages 19420-19439.
Crossref
Enaam Abdelrhman Abdelgader, Nada Hassan Eltayeb, Tasniem Ahmed Eltahir, Osama Ali Altayeb, Eman Abbass Fadul, Eldirdiri M. Abdel Rahman & Tarig H. Merghani. (2018) Evaluation of CD38 expression in Sudanese patients with chronic lymphocytic leukemia. BMC Research Notes 11:1.
Crossref
Hadeer A. Abbassy, Reham A. Aboelwafa & Omar M. Ghallab. (2017) Evaluation of Interleukin-9 Expression as a Potential Therapeutic Target in Chronic Lymphocytic Leukemia in a Cohort of Egyptian Patients. Indian Journal of Hematology and Blood Transfusion 33:4, pages 477-482.
Crossref
Nicolas Poret, Qiangwei Fu, Soizic Guihard, Meyling Cheok, Katie Miller, Gordon Zeng, Bruno Quesnel, Xavier Troussard, Sylvie Galiègue-Zouitina & Carl Simon Shelley. (2015) CD38 in Hairy Cell Leukemia Is a Marker of Poor Prognosis and a New Target for Therapy. Cancer Research 75:18, pages 3902-3911.
Crossref
Panagiotis G. Adamopoulos, Christos K. Kontos, Sotirios G. Papageorgiou, Vassiliki Pappa & Andreas Scorilas. (2015) KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia. Clinical Biochemistry 48:13-14, pages 849-854.
Crossref
Elizabeth C. Chastain & Eric J. Duncavage. (2015) Clinical Prognostic Biomarkers in Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma. Archives of Pathology & Laboratory Medicine 139:5, pages 602-607.
Crossref
ÖZLEM COŞKUN & RÜSTEM NURTEN. (2013) Purification of NAD+ glycohydrolase from human serum. Oncology Letters 6:1, pages 227-231.
Crossref
IşIL ALBENİZ, LEYLA TÜRKER-ŞENER, AYCAN BAŞ, İBRAHIM KALELİOĞLU & RÜSTEM NURTEN. (2012) Isolation of hematopoietic stem cells and the effect of CD38 expression during the early erythroid progenitor cell development process. Oncology Letters 3:1, pages 55-60.
Crossref
Fabio MalavasiSilvia DeaglioRajendra Damle, Giovanna Cutrona, Manlio Ferrarini & Nicholas Chiorazzi. (2011) CD38 and chronic lymphocytic leukemia: a decade later. Blood 118:13, pages 3470-3478.
Crossref
Lingzhi Zhang, Fiona Murray, Laura Z. Rassenti, Minya Pu, Colleen Kelly, Joan R. Kanter, Andrew Greaves, Karen Messer, Thomas J. Kipps & Paul A. Insel. (2011) Cyclic nucleotide phosphodiesterase 7B mRNA: An unfavorable characteristic in chronic lymphocytic leukemia. International Journal of Cancer 129:5, pages 1162-1169.
Crossref
E Ferretti, M Bertolotto, S Deaglio, C Tripodo, D Ribatti, V Audrito, F Blengio, S Matis, S Zupo, D Rossi, L Ottonello, G Gaidano, F Malavasi, V Pistoia & A Corcione. (2011) A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. Leukemia 25:8, pages 1268-1277.
Crossref
IŞIL ALBENIZ, ÖZLEM DEMIR-COŞKUN, LEYLA TÜRKER-ŞENER, AYCAN BAŞ, OKTAR ASOĞLU & RÜSTEM NURTEN. (2011) CD38 expression as response of hematopoietic system to cancer. Oncology Letters 2:4, pages 659-664.
Crossref
Esther Kellenberger, Isabelle Kuhn, Francis Schuber & Hélène Muller-Steffner. (2011) Flavonoids as inhibitors of human CD38. Bioorganic & Medicinal Chemistry Letters 21:13, pages 3939-3942.
Crossref
Tiziana Vaisitti, Valentina Audrito, Sara Serra, Cinzia Bologna, Davide Brusa, Fabio Malavasi & Silvia Deaglio. (2011) NAD + -metabolizing ecto-enzymes shape tumor-host interactions: The chronic lymphocytic leukemia model . FEBS Letters 585:11, pages 1514-1520.
Crossref
Silvia Deaglio, Tiziana Vaisitti, Antonella Zucchetto, Valter Gattei & Fabio Malavasi. (2010) CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells. Seminars in Cancer Biology 20:6, pages 416-423.
Crossref
T Vaisitti, S Aydin, D Rossi, F Cottino, L Bergui, G D'Arena, L Bonello, A L Horenstein, P Brennan, C Pepper, G Gaidano, F Malavasi & S Deaglio. (2010) CD38 increases CXCL12-mediated signals and homing of chronic lymphocytic leukemia cells. Leukemia 24:5, pages 958-969.
Crossref
Silvia Deaglio & Semra Aydin. (2010) . Molecular Medicine 16:3-4, pages 1.
Crossref
Michele Dal-Bo, Francesco Bertoni, Francesco Forconi, Antonella Zucchetto, Riccardo Bomben, Roberto Marasca, Silvia Deaglio, Luca Laurenti, Dimitar G Efremov, Gianluca Gaidano, Giovanni Del Poeta & Valter Gattei. (2009) Intrinsic and extrinsic factors influencing the clinical course of B-cell chronic lymphocytic leukemia: prognostic markers with pathogenetic relevance. Journal of Translational Medicine 7:1.
Crossref
Keichiro Mihara, Kazuyoshi Yanagihara, Misato Takigahira, Chihaya Imai, Akira Kitanaka, Yoshihiro Takihara & Akiro Kimura. (2009) Activated T–cell-mediated Immunotherapy With a Chimeric Receptor Against CD38 in B-cell Non-Hodgkin Lymphoma. Journal of Immunotherapy 32:7, pages 737-743.
Crossref
Fabiola Quintero-Rivera, Farzad Nooraie & P. Nagesh Rao. (2009) Frequency of 5′IGH deletions in B-cell chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics 190:1, pages 33-39.
Crossref
Hong Jiang, Johanna Congleton, Qun Liu, Paolomi Merchant, Fabio Malavasi, Hon Cheung Lee, Quan Hao, Andrew Yen & Hening Lin. (2009) Mechanism-Based Small Molecule Probes for Labeling CD38 on Live Cells. Journal of the American Chemical Society 131:5, pages 1658-1659.
Crossref
Femke Van Bockstaele, Bruno Verhasselt & Jan Philippé. (2009) Prognostic markers in chronic lymphocytic leukemia: A comprehensive review. Blood Reviews 23:1, pages 25-47.
Crossref
Laura Z. RassentiSonia JainMichael J. KeatingWilliam G. WierdaMichael R. GreverJohn C. ByrdNeil E. KayJennifer R. BrownJohn G. Gribben, Donna S. NeubergFeng HeAndrew W. GreavesKanti R. Rai & Thomas J. Kipps. (2008) Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia. Blood 112:5, pages 1923-1930.
Crossref
Semra AydinDavide RossiLuciana BerguiGiovanni D'ArenaEnza FerreroLisa BonelloPaola OmedéDomenico NoveroFortunato Morabito, Antonino Carbone, Gianluca GaidanoFabio MalavasiSilvia Deaglio. (2008) CD38 gene polymorphism and chronic lymphocytic leukemia: a role in transformation to Richter syndrome?. Blood 111:12, pages 5646-5653.
Crossref
Silvia Deaglio, Semra Aydin, Tiziana Vaisitti, Luciana Bergui & Fabio Malavasi. (2008) CD38 at the junction between prognostic marker and therapeutic target. Trends in Molecular Medicine 14:5, pages 210-218.
Crossref
Göran RoosAlexander Kröber, Pawel GrabowskiDirk Kienle, Andreas Bühler, Hartmut Döhner, Richard Rosenquist & Stephan Stilgenbauer. (2008) Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood 111:4, pages 2246-2252.
Crossref
Silvia DeaglioTiziana VaisittiSemra AydinLuciana BerguiGiovanni D'ArenaLisa BonelloPaola OmedéMaria ScatoliniOzren Jaksic, Giovanna ChiorinoDimitar Efremov & Fabio Malavasi. (2007) CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential. Blood 110:12, pages 4012-4021.
Crossref
Bharat N. Nathwani, Sebastian J. Sasu, Arshad N. Ahsanuddin, Antonio M. Hernandez & Milton R. Drachenberg. (2007) The Critical Role of Histology in an Era of Genomics and Proteomics: A Commentary and Reflection. Advances in Anatomic Pathology 14:6, pages 375-400.
Crossref
Avadhut D. Joshi, Ganapati V. Hegde, John D. Dickinson, Amit K. Mittal, James C. Lynch, James D. Eudy, James O. Armitage, Philip J. Bierman, R. Gregory Bociek, Marcel P. Devetten, Julie M. Vose & Shantaram S. Joshi. (2007) ATM, CTLA4, MNDA , and HEM1 in High versus Low CD38–Expressing B-Cell Chronic Lymphocytic Leukemia . Clinical Cancer Research 13:18, pages 5295-5304.
Crossref
Silvia DeaglioTiziana VaisittiRichard BillingtonLuciana Bergui, Paola Omede', Armando A. GenazzaniFabio Malavasi. (2007) CD38/CD19: a lipid raft–dependent signaling complex in human B cells. Blood 109:12, pages 5390-5398.
Crossref
Constantine S. Tam, William Wierda, Susan Lerner & Michael J. Keating. (2007) Chronic Lymphocytic Leukemia: How to Assess Prognosis in 2007. Clinical Leukemia 1:3, pages 162-167.
Crossref
Amal Mansour, Victor T. Chang, Shanti Srinivas, Jonathan Harrison & Elizabeth Raveche. (2006) Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein. Cancer Immunology, Immunotherapy 56:4, pages 501-514.
Crossref
Armando Gregorini, Marco Tomasetti, Cristina Cinti, Daniela Colomba & Stella Colomba. (2013) CD38 expression enhances sensitivity of lymphoma T and B cell lines to biochemical and receptor‐mediated apoptosis. Cell Biology International 30:9, pages 727-732.
Crossref
Silvia DeaglioTiziana VaisittiSemra AydinEnza FerreroFabio Malavasi. (2006) In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia. Blood 108:4, pages 1135-1144.
Crossref
Bruce H. Davis & Michael Schwartz. (2006) ZAP-70 expression is low in normal precursor B cells or hematogones. Cytometry Part B: Clinical Cytometry 70B:4, pages 314-318.
Crossref
Frances E. Lund, Hélène Muller-Steffner, Héctor Romero-Ramirez, Miguel E. Moreno-García, Santiago Partida-Sánchez, Melissa Makris, Norman J. Oppenheimer, Leopoldo Santos-Argumedo & Francis Schuber. (2006) CD38 induces apoptosis of a murine pro-B leukemic cell line by a tyrosine kinase-dependent but ADP-ribosyl cyclase- and NAD glycohydrolase-independent mechanism. International Immunology 18:7, pages 1029-1042.
Crossref
Andreas Jakob, Jasmin Doll, Jürgen Schulte-Mönting & Friedrich W. Hirsch. (2006) Retrospective Analysis of CD38 Expression in 102 Patients with B-CLL with a Maximum Follow-Up of 18 Years: Incidence and Prognostic Significance. Oncology Research and Treatment 29:10, pages 437-441.
Crossref
Gábor Méhes. (2005) Chromosome abnormalities with prognostic impact in B-cell chronic lymphocytic leukemia. Pathology & Oncology Research 11:4, pages 205-210.
Crossref
. (2005) Current Awareness in Hematological Oncology. Hematological Oncology 23:3-4, pages 136-143.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.